IDEAS home Printed from https://ideas.repec.org/a/eee/hepoli/v162y2025ics0168851025002246.html

Determinants of time to access to EMA-approved cancer drugs in Spanish NHS in the past decade: a two cohorts study

Author

Listed:
  • Nieto-Gómez, Pelayo
  • Castaño-Amores, Celia
  • García-Ruiz, Antonio José
  • Oliva-Moreno, Juan

Abstract

Spain is the fourth largest pharmaceutical market in Europe, yet the time to reimbursement for cancer drugs has been considerably longer than in other European countries in recent years.

Suggested Citation

  • Nieto-Gómez, Pelayo & Castaño-Amores, Celia & García-Ruiz, Antonio José & Oliva-Moreno, Juan, 2025. "Determinants of time to access to EMA-approved cancer drugs in Spanish NHS in the past decade: a two cohorts study," Health Policy, Elsevier, vol. 162(C).
    • Handle: RePEc:eee:hepoli:v:162:y:2025:i:c:s0168851025002246
    DOI: 10.1016/j.healthpol.2025.105469
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0168851025002246
    Download Restriction: Full text for ScienceDirect subscribers only
    File URL: https://libkey.io/10.1016/j.healthpol.2025.105469?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to

    for a different version of it.

    References listed on IDEAS

    as
    1. Thomas Hofmarcher & Caroline Berchet & Guillaume Dedet, 2024. "Access to oncology medicines in EU and OECD countries," OECD Health Working Papers 170, OECD Publishing.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Delcroix-Lopes, Sophie & Amer, Nadia & Chaignot, Christophe & Pelletan, Charlotte, 2025. "Early access to medicines with added therapeutic value: Measuring and comparing time to medicines access in England, France, Germany, Italy and Spain," Health Policy, Elsevier, vol. 157(C).

    More about this item

    Keywords

    ;
    ;
    ;
    ;
    ;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:162:y:2025:i:c:s0168851025002246. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.